Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2

Diabetes

Volumn 52, Issue 6, 2003, Pages 1340-1346

  El Haschimi, Karim ^a,b   Dufresne, Scott D ^c   Hirshman, Michael F ^c   Flier, Jeffrey S ^a   Goodyear, Laurie J ^c   Bjørbæk, Christian ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; PROTEIN SERINE THREONINE KINASE; RIBOSOMAL S6 KINASE 2; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; BODY MASS; BODY WEIGHT; CELL STIMULATION; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FOOD INTAKE; GENE FUNCTION; GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPODYSTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; AGING; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; GLUCOSE INTOLERANCE; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPODYSTROPHY; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA;

EID: 0038660080     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.6.1340     Document Type: Article

References (64)

1. Frodin M, Gammeltoft S: Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151:65-77, 1999
2. Sturgill TW, Ray LB, Erikson E, Maller JL: Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334:715-718, 1988
3. Erikson E, Maller JL: A protein kinase from Xenopus eggs specific for ribosomal protein S6. Proc Natl Acad Sci U S A 82:742-746, 1985
4. Jones SW, Erikson E, Blenis J, Maller JL, Erikson RL: A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases. Proc Natl Acad Sci U S A 85:3377-3381, 1988
5. Kyriakis JM, Avruch J: S6 Kinases and MAP Kinases: Sequential Intermediates in Insulin/Mitogen Activated Protein Kinase Cascades. Oxford, UK, Oxford University Press, 1994, p. 85-148
6. Thomas G: p70s6K/p85s6k: mechanism of activation, effects of rapamycin and role in mitogenesis. Biochem Soc Trans 21:901-904, 1993
7. Moller DE, Xia CH, Tang W, Zhu AX, Jakubowski M: Human RSK isoforms: cloning and characterization of tissue-specific expression. Am J Physiol 266:C351-C359, 1994
8. Zhao Y, Bjørbæk C, Weremowicz S, Morton CC, Moller DE: RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation. Mol Cell Biol 8:4353-4363, 1995
9. Yntema HG, van den Helm B, Kissing J, van Duijnhoven G, Poppelaars F, Chelly J, Moraine C, Fryns JP, Hamel BC, Heilbronner H, Pander HJ, Brunner HG, Ropers HH, Cremers FP, van Bokhoven H: A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. Genomics 62:332-343, 1999
10. Bjørbæk C, Vik TA, Echwald SM, Yang PY, Vestergaard H, Wang JP, Webb GC, Richmond K, Hansen T, Erikson RL, Gabor Miklos GL, Cohen PTW, Pedersen O: Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients. Diabetes 44:90-97, 1995
11. Pierrat B, Correia JS, Mary JL, Tomas-Zuber M, Lesslauer W: RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alphaMAPK). J Biol Chem 273:29661-29671, 1998
12. Deak M, Clifton AD, Lucocq LM, Alessi DR: Mitogen-and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38 and may mediate activation of CREB. EMBO J 17:4426-4421, 1998
13. Chen RH, Sarnecki C, Blenis J: Nuclear localisation and regulation of erk-and rsk-encoded protein kinases. Mol Cell Biol 3:915-927, 1992
14. Zhang Y, Zhong S, Dong Z, Chen N, Bode AM, Ma W, Dong Z: UVA induces Ser381 phosphorylation of p90RSK/MAPKAP-K1 via ERK and JNK pathways. J Biol Chem 276:14572-14580, 2001
15. Merienne K, Jacquot S, Zeniou M, Pannetier S, Sassone-Corsi P, Hanauer A: Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway. Oncogene 19:4221-4229, 2000
16. Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen RH, Blenis J, Greenberg ME: A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol Cell Biol 10:6260-6273, 1993
17. Chen RH, Chung J, Blenis J: Regulation of pp90rsk phosphorylation and S6 phospotransferase activity in Swiss 3T3 cells by growth factor-, phorbol ester-, and cyclic AMP-mediated signal transduction. Mol Cell Biol 4:1861-1867, 1991
18. Frodin M, Antal TL, Dummler BA, Jensen CJ, Deak M, Gammeltoft S, Biondi RM: A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J 21:5396-5407, 2002
19. Lawlor MA, Mora A, Ashby PR, Williams MR, Murray-Tait V, Malone L, Prescott AR, Lucocq JM, Alessi DR: Essential role of PDK1 in regulating cell size and development in mice. EMBO J 21:3728-3738, 2002
20. Dalby KN, Morrice N, Caudwell FB, Avruch J, Cohen P: Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J Biol Chem 273:1496-1505, 1998
21. Sutherland C, Campbell DG, Cohen P: Identification of insulin-stimulated protein kinase-1 as the rabbit equivalent of rskmo-2: identification of two threonines phosphorylated during activation by mitogen-activated protein kinase. Eur J Biochem 212:581-588, 1993
22. Fisher TL, Blenis J: Evidence of two catalytical active kinase domains in pp90rsk. Mol Cell Biol 3:1212-1219, 1996
23. Zhao Y, Bjørbæk C, Moller DE: Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases. J Biol Chem 271:29773-29779, 1996
24. Bjørbæk C, Zhao Y, Moller DE: Divergent functional roles for p90rsk kinase domains. J Biol Chem 270:18848-18852, 1995
25. Chen RH, Abate C, Blenis J: Phosphorylation of the c-fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc Natl Acad Sci U S A 90:10952-10956, 1993
26. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P: Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci U S A 95:12202-12207, 1998
27. Xing J, Ginty DD, Greenberg ME: Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273:959-963, 1996
28. Erikson E, Maller JL: Substrate specificity of ribosomal protein S6 kinase II from Xenopus eggs. Second Messengers Phospoproteins 12:135-143, 1988
29. Sassone-Corsi P, Mizzen CA, Cheung P, Crosio C, Monaco L, Jacquot S, Hanauer A, Allis CD: Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285:886-891, 1999
30. Eldar-Finkelman H, Seger R, Vandenheede JR, Krebs EG: Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J Biol Chem 270:987-990, 1995
31. Tan Y, Ruan H, Demeter MR, Comb MJ: p90(RSK) blocks bad-mediated cell death via protein kinase C-dependent pathway. J Biol Chem 274:34859-35867, 1999
32. Blenis J: Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A 90:5889-5892, 1993
33. Zeniou M, Ding T, Trivier E, Hanauer A: Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. Hum Mol Genet 23:2929-2940, 2002
34. Trivier E, De Cesare D, Jacquot S, Pannetier S, Zackai E, Young I, Mandel JL, Sassone-Corsi P, Hanauer A: Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384:567-570, 1996
35. Jacquot S, Merienne K, Pannetier S, Blumenfeld S, Schinzel A, Hanauer A: Germline mosaicism in Coffin-Lowry syndrome. Eur J Hum Genet 6:578-582, 1998
36. Coffin GS, Siris E, Wegienka LC: Mental retardation with osteocartilaginous anomalies. Am J Dis Child 112:205-213, 1966
37. Lowry B, Miller JR, Fraser FC: A new dominant gene mental retardation syndrome. Am J Dis Child 121:496-500, 1971
38. Young ID: The Coffin-Lowry syndrome. J Med Genet 25:344-348, 1988
39. Dufresne SD, Bjørbæk C, El-Haschimi K, Zhao Y, Aschenbach WG, Moller DE, Goodyear LJ: Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol Cell Biol 21:81-87, 2001
40. Salmon DM, Flatt JP: Effect of dietary fat content on the incidence of obesity among ad libitum fed mice. Int J Obes 9:443-449, 1985
41. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR, Kahn BB: Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 8:924-928, 2000.
42. Harris RB, Zhou J, Redmann SM Jr, Smagin GN, Smith SR, Rodgers E, Zachwieja JJ: A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 139:8-19, 1998
43. Van Heek M, Compton D, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis HR Jr. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99:385-390, 1997
44. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 106:473-481, 2000
45. Virtanen KA, Lonnroth P, Parkkola R, Peltoniemi P, Asola M, Viljanen T, Tolvanen T, Knuuti J, Ronnemaa T, Huupponen R, Nuutila P: Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 87:3902-3910, 2002
46. Reitman ML, Gavrilova O: A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes. Int J Obes Retat Metab Disord 24 (Suppl. 4):S11-S14, 2000
47. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G: Analysis of paradoxical observations on the association between leptin and insulin. FASEB J 10:1163-1176, 2002
48. Barzilai N, She L, Liu L, Wang J, Hu M, Vuguin P, Rossetti L: Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action. Am J Physiol 277:E291-E298, 1999
49. Yaspelkis BB 3rd, Ansari L, Ramey EL, Holland GJ, Loy SF: Chronic leptin administration increases insulin-stimulated skeletal muscle glucose uptake and transport. Metabolism 48:671-676, 1999
50. Reue K, Peterfy M: Mouse models of lipodystrophy. Curr Atheroscler Rep 5:390-396, 2000
51. Sone H, Takahashi A, Iida K, Yamada N: Disease model: hyperinsulinemia and insulin resistance. Part B: polygenic and other animal models. Trends Mol Med 8:373-376, 2001
52. Velasque MT, Bhathena SJ, Hansen CT: Leptin and its relation to obesity and insulin in the SHR/N-corpulent rat, a model of type II diabetes mellitus. Int J Exp Diabetes Res 2:217-223, 2001
53. Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401:73-76, 1999
54. Chang PY, Le Marchand-Brustel Y, Cheatham LA, Moller DE: Insulin stimulation of mitogen-activated protein kinase, p90rsk, and p70 S6 kinase in skeletal muscle of normal and insulin-resistant mice: implications for the regulation of glycogen synthase. J Biol Chem 270:29928-29935, 1995
55. Dent P, Lavoinne A, Nakielny S, Caudwell FB, Watt P, Cohen P: The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348:302-308, 1990
56. Bertolotto C, Maulon L, Filippa N, Baier G, Auberger P: Protein kinase C theta and epsilon promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD. J Biol Chem 275:37246-37250, 2000
57. She QB, Ma WY, Zhong S, Dong Z: Activation of JNK1, RSK2, and MSK1 is involved in serine 112 phosphorylation of BAD by ultraviolet B radiation. J Biol Chem 277:24039-24048, 2002
58. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 11:1288-1295, 2002
59. Stefan N, Stumvoll M: Adiponectin: its role in metabolism and beyond. Horm Metab Res 34:469-474, 2002
60. Barth N, Langmann T, Scholmerich J, Schmitz G, Schaffler A: Identification of regulatory elements in human adipose most abundant gene transcript-1 (apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways. Diabetologia 45:1425-1433, 2002
61. Greenberg AS, McDaniel ML: Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32:24-34, 2002
62. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL: Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natt Acad Sci U S A 96:13656-13661, 1999
63. Gavrilova O, Marcus-Samuels B, Leon LR, Vinson C, Reitman ML: Leptin and diabetes in lipoatrophic mice. Nature 403:850-851, 2000
64. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI: Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345-1350, 2002